SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13D

Under the Securities Exchange Act of 1934
(Amendment No. 7)*

Royce Focus Trust, Inc.
(Name of Issuer)

Common Stock
(Title of Class of Securities)

78080N108
(CUSIP Number)

Charles M. Royce, 745 Fifth Avenue, New York, New York 10151, (212) 508-4500
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)

 

January 26, 2011
(Date of Event which Requires Filing
of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(b)(3) or (4), check the following box [  ].

Note: Six copies of this statement, including all exhibits, should be filed with the Commission. See Rule 13d-1(a) for other parties to whom copies are to be sent.

* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

(Continued on following page(s))

Page 1 of 5 Pages

CUSIP No. 78080N108

13D

Page 2 of 5 Pages

1

NAME OF REPORTING PERSON

I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

Charles M. Royce

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ]

                                                                               (b) [ ]

3

SEC USE ONLY

 

4

SOURCE OF FUNDS*

PF

5

CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT

TO ITEMS 2(d) OR 2(e)                                                                        [ ]

6

CITIZENSHIP OR PLACE OF ORGANIZATION

U.S.A.

 

NUMBER OF

SHARES

BENEFICIALLY

7

SOLE VOTING POWER

1,497,112

OWNED BY

EACH

REPORTING

8

SHARED VOTING POWER

 

PERSON

WITH

9

SOLE DISPOSITIVE POWER

1,497,112
 

10

SHARED DISPOSITIVE POWER

11

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH

REPORTING PERSON

1,497,112

12

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES

CERTAIN SHARES*                                                                     [ ]

CUSIP No. 78080N108

13D

Page 3 of 5 Pages

13

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

7.58%

14

TYPE OF REPORTING PERSON*

IN

 

* SEE INSTRUCTIONS BEFORE FILLING OUT!

CUSIP No. 78080N108

13D

Page 4 of 5 Pages

Item 1.        Security and Issuer.
 

        The title and class of equity securities to which this statement relates is Common Stock.
 

        The name and address of the principal executive offices of the Issuer are:
 

                Royce Focus Trust, Inc.

                745 Fifth Avenue

                New York, New York 10151
 

Item 2.        Identity and Background.
 

(a)        The name of the person filing this statement is Charles M. Royce.
 

(b)        Mr. Royce's business address is 745 Fifth Avenue, New York, New York 10151.
 

(c)        Mr. Royce is President, Co-Chief Investment Officer and a member of the Board of Managers of Royce & Associates, LLC, a registered investment adviser whose clients include the Issuer and other registered investment companies. He is director/trustee and President of the Issuer and such other investment companies. These companies are located at 745 Fifth Avenue, New York, New York 10151.
 

(d)        Not applicable.
 

(e)        Not applicable.
 

(f)        Mr. Royce is a citizen of the United States.
 
 

Item 3.        Source and Amount of Funds or Other Consideration.
 

        Not applicable.
 

Item 4.        Purpose of Transaction.
 

        This schedule is being filed as a result of the sale of 151,908 shares of the Issuer's Common Stock over which Charles M. Royce had sole investment and voting discretion, in January - February 2011, for an aggregate value of $1,164,472, which decreased Mr. Royce's beneficial holdings of the Issuer's Common Stock in excess of one additional percentage point.
 

CUSIP No. 78080N108

13D

Page 5 of 5 Pages

Item 5.        Interest in Securities of Issuer.
 

(a)       Mr. Royce had sole investment and voting discretion over 1,497,112 shares or 7.58% of the Issuer's outstanding Common Stock as of February 4, 2011. This amount included 42,640 shares held by a charitable foundation in which Mr. Royce has no pecuniary interest.
 

(b)        Mr. Royce has sole voting and sole dispositive powers as to all of the shares shown in item 5(a) above.

 

(c)        In the 60 days prior to the date of filing of this statement, Mr. Royce effected the following sales of the Common Stock of the Issuer, which were effected in the open market and not previously reported on any Schedule 13D filing: (i) 59,000 shares @$7.61 on January 26, 2011, (ii) 20,000 shares @ $7.67 on January 27, 2011, (iii) 20,000 shares @ $7.62 on January 31, 2011, (iv) 30,000 shares @ $7.70 on February 1, 2011, (v) 10,000 shares @ $7.80 on February 2, 2011 and (vi) 12,908 shares @ $7.80 on February 3, 2011.
 

Item 6.        Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.
 

        Not applicable.
 

Item 7.        Materials to be Filed as Exhibits.
 

        Not applicable.

 

SIGNATURE

        After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

February 4, 2011                   

        (Date)

/s/ Dani Eng,                     

        (Signature)

Dani Eng, Attorney-in-Fact